CYP2C9 polymorphism is associated with susceptibility to ischemic stroke in a Chinese population. 2025

Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
Gerontological Center, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Ischemic stroke (IS) is a global cerebrovascular disease with high morbidity and mortality. CYP2C9 genetic variants are significantly involved in the development of many diseases. However, the impacts that CYP2C9 genetic variants on the risk of IS remain to be comprehensively understood. We aim to determine the association of CYP2C9 with IS susceptibility in the Chinese Han population. This study recruited a total of 643 patients with IS and 643 healthy controls. CYP2C9 single-nucleotide polymorphisms (SNPs) were tested by the MassARRAY iPLEX platform. The associations of CYP2C9 polymorphisms (rs10509679, rs1934967, rs1934968, and rs9332220) and IS risk were analysed by the logistic regression analysis. Our study showed that rs10509679 G > A was significantly related to increased risk of IS (OR= 1.48, 95% CI= 1.05-2.09, p = 0.024). The stratified analysis further demonstrated that rs10509679 was correlated with an increased susceptibility to IS patients in subgroups of people aged> 60 years, those with BMI< 24, smokers, drinkers, and those without diabetes. False-positive report probability analysis was further carried out to verify the significant findings. In haplotype analysis, individuals carrying the Ars10509679Crs1934967Grs1934968Grs9332220 haplotype exhibit an elevated risk of IS occurrence. In summary, CYP2C9 rs10509679 G > A may be associated with the risk of IS.

UI MeSH Term Description Entries

Related Publications

Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
January 2025, PeerJ,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
September 2011, Journal of the neurological sciences,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
April 2024, Clinical neurology and neurosurgery,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
August 2016, Cellular and molecular neurobiology,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
January 2022, Neuropsychiatric disease and treatment,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
January 2022, Frontiers in neurology,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
September 2021, Biomedical reports,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
December 2017, Neuroscience bulletin,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
May 2010, Progress in neuro-psychopharmacology & biological psychiatry,
Jinglu Zhang, and Haiyu Jia, and Yun Liu, and Yong Zhang, and Haihong Nie, and Qiuhong Bao
May 2008, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!